. Author manuscript; available in PMC: 2020 Nov 4.

Published in final edited form as: Mol Imaging Biol. 2014 Oct;16(5):739–746. doi: 10.1007/s11307-014-0730-7

TABLE 4.

Comparison of Dose per Unit Administered Activity Between ¹⁸F-VM4–037 and Other ¹⁸F Based Imaging Agents

	VM4–037		FDG	Galacto-RGD	HX4
Bladder Voiding Interval	1 hr	4.8 hr	4.8 hr	2 hr	1 hr	4.8 hr
Total Body Dose (μGy/MBq)	15	15	11	5.34	8	10
Effective dose (μSv/MBq)	26	28	19	18.68	14	27